GENV-HEMHEMOPHILIA
Hemophilia-focused gene therapy research
Research exploring gene therapy approaches for hemophilia and the challenges of hemostasis.
Explore GENV-HEM ↗ SCIENCE · PEOPLE · POSSIBILITY
Advancing the possibilities of gene therapy.
Developing gene therapy approaches for serious genetic diseases through focused science and thoughtful innovation.
GENEVENTIV THERAPEUTICSSCROLL TO EXPLORE ↓
OUR APPROACHPrecision science.
Precision science.
Purposeful progress.
GeneVentiv is exploring gene therapy strategies designed to address the underlying biology of inherited disease.
Our work brings together delivery technologies and disease-focused research, with the goal of developing new therapeutic possibilities.
Discover our programs ↗OUR PIPELINE
Programs in focus
A snapshot of our disease-focused research. Explore each program for more information.
GENV-002POMPE DISEASE
A liver-based approach for Pompe disease
An investigational approach intended to make the liver a systemic source of circulating GAA enzyme.
Explore GENV-002 ↗CONTACT USLet’s advance
Let’s advance
what’s possible.
Connect with GeneVentiv to learn more about our science, programs, and opportunities for collaboration.
Contact GeneVentiv ↗